![Methylene Blue vs NAD+: Which Is Better for Cellular Energy? [2026 Comparison] – NooBlue Methylene Blue Capsules 5mg bottle](https://supplement.codeblex.com/wp-content/uploads/2026/04/methylene-blue-vs-nad-which-is-better-for-cellular-energy-2026-comparison-featured.jpg)
By the NooBlue editorial team. NooBlue sells methylene blue. We do not sell NAD+ precursors, so we have kept the NAD+ sections to what the published trials show. This page is general information, not medical advice.
Quick answer
Methylene blue and NAD+ work on the same energy pathway from opposite ends. Methylene blue is a redox dye that can take electrons from NADH and pass them along the mitochondrial chain, which turns NADH back into NAD+. NAD+ precursors (nicotinamide riboside, or NR, and nicotinamide mononucleotide, or NMN) add to the total NAD+ pool.
Neither is better across the board. Methylene blue has two small placebo-controlled human trials showing changes in brain activity one hour after a single dose. NR and NMN have more trials, and they reliably raise blood NAD+, but trials have not shown that this makes healthy people feel more energetic. No trial has tested the two together.
Safety decides it for some people. Methylene blue must not be combined with SSRIs, SNRIs or other serotonergic medicines, and it is not for anyone with G6PD deficiency or who is pregnant or breastfeeding. NR and NMN were well tolerated in trials lasting up to 12 weeks.
Searches for NAD and methylene blue bring up a mix of clinic pages selling infusions of both, supplement brands, and a few cell studies. This guide sorts out what each compound does, what the human trials actually measured, how the two connect through NADH, and which one fits which reader. It also answers the questions people ask most: whether you can take them together, and what not to mix with each.
Methylene blue vs NAD+ at a glance
| Methylene blue | NAD+ precursors (NR, NMN) | |
|---|---|---|
| What it is | A synthetic redox dye, used in medicine for about a century | Vitamin B3 compounds the body converts into NAD+ |
| What it does | Carries electrons from NADH toward cytochrome c, and blocks the enzyme MAO-A | Adds to the NAD+ pool that cells use to carry electrons and run signaling enzymes |
| Amounts in human studies | A single 280 mg dose. Supplements are sold in 5 to 10 mg servings | NR: single doses of 100 to 1,000 mg, and 1,000 mg a day. NMN: 250 to 900 mg a day |
| Human evidence | Two small single-dose brain imaging trials in healthy adults | Several randomized trials, mostly small and often run or funded by ingredient makers |
| What was measured | Brain activity and memory one hour after the dose | Blood NAD+ levels over days to weeks, plus some physical tests |
| Main safety issues | Serotonin syndrome with serotonergic medicines. Not for G6PD deficiency, pregnancy or breastfeeding. Blue urine | Mild, infrequent side effects in trials of up to 12 weeks. Little long-term or interaction data |
| Cost per serving | From $0.30 per 5 mg serving (NooBlue 1% drops, as of Sep 2026) | Varies widely by brand and dose. Compare the price per 250 mg |
How methylene blue works
Your mitochondria make most of your energy by passing electrons down a chain of protein complexes. NADH hands electrons to the start of the chain, and oxygen takes them at the end. The flow drives the production of ATP, the molecule cells spend as energy. Our primer on what cellular energy is covers the chain in more detail.
Methylene blue can join that chain as an extra carrier. In a 2011 study in the Journal of Biological Chemistry, Wen and colleagues showed that methylene blue accepts electrons from NADH and passes them to cytochrome c, which lets electrons bypass complexes I and III. In cultured nerve cells it raised oxygen use and reduced the reliance on glycolysis (Wen et al., 2011). An earlier study by Atamna and colleagues, including Bruce Ames, found that in human fibroblasts grown in the lab, methylene blue raised the activity of complex IV by 30% and oxygen use by 37% to 70%. The authors proposed that it works by cycling between its blue form and its colorless reduced form, leucomethylene blue (Atamna et al., 2008).
Two points matter here. First, these are cell and animal results. They explain why researchers are interested in methylene blue, and they cannot tell you what a 5 mg capsule does in a person. Second, the cycling is why methylene blue is dosed in milligrams: one molecule can be reduced and reoxidized many times. Our explainer on leucomethylene blue covers the two forms, and our methylene blue for energy guide goes further into the mechanism.
Methylene blue has a second action that has nothing to do with energy. It is a potent, reversible inhibitor of monoamine oxidase A (MAO-A), the enzyme that breaks down serotonin (Ramsay et al., 2007). That property drives its most serious safety rule, covered below.
How NAD+ and its precursors work
NAD+ (nicotinamide adenine dinucleotide) is an electron carrier used throughout cellular metabolism. When it picks up electrons it becomes NADH, which delivers them to the mitochondrial chain. NAD+ is also consumed by signaling enzymes, including the sirtuins and the PARP enzymes that respond to DNA damage. A 2019 study of healthy people across a wide age range found lower plasma NAD+ with age and higher levels of its reduced form, NADH (Clement et al., 2019). That age-related drop is the main case for NAD+ supplements.
Swallowed NAD+ is not the usual route. The supplements that have been tested in people are precursors. Nicotinamide riboside (NR) is a vitamin B3 compound, and nicotinamide mononucleotide (NMN) sits one step closer to NAD+ in the same pathway. Both are taken in hundreds of milligrams a day, because each molecule is used up as it is converted.
Clinics also sell intravenous NAD+. The human data on it are thin. In a 2019 pilot study, researchers infused NAD+ over six hours and found no change in plasma NAD+ or its breakdown products for the first two hours: the infused NAD+ was removed from the blood as fast as it went in (Grant et al., 2019). That study measured blood chemistry, not how people felt.
The NADH link between methylene blue and NAD+
The two compounds are more connected than the usual “fast versus slow” framing suggests. Methylene blue takes electrons from NADH. Each time it does, one NADH becomes NAD+ again. So methylene blue shifts the balance between the two forms, while NR and NMN raise the total amount.
One of the studies that ranks for this search tested exactly that in cells. In a 2015 paper in Redox Biology, Atamna and colleagues found that methylene blue produced a transient rise in the NAD/NADH ratio in human lung fibroblasts. The rise was followed by activation of AMPK, the cell’s energy sensor, then higher levels of PGC1α, which drives the build-up of mitochondria. Treated cells showed more than a 100% increase in complex IV activity and a 28% fall in cellular oxidants (Atamna et al., 2015).
In practical terms: methylene blue recycles the NAD+ you already have, and precursors add to the pool. That is the whole argument for pairing them, and it is a reasonable one on paper. It has not been tested in people. Nobody has measured the NAD/NADH ratio in humans taking supplement doses of methylene blue, and no trial has given methylene blue and an NAD+ precursor together.
What the human trials show
Methylene blue
The best-known human study is a 2016 randomized, double-blind, placebo-controlled trial published in Radiology. Twenty-six healthy adults aged 22 to 62 took either a single 280 mg oral dose of methylene blue (about 4 mg/kg) or a placebo. One hour later, the methylene blue group showed more brain activity on functional MRI during attention and short-term memory tasks, and a 7% increase in correct memory-retrieval responses (Rodriguez et al., 2016). A 2017 follow-up with 28 participants used the same single dose and found stronger resting-state connectivity between brain regions involved in perception and memory (Rodriguez et al., 2017).
What those trials did not test: daily use, the 5 to 10 mg servings sold as supplements, energy or fatigue as outcomes, or anyone taking psychiatric medication, whom both trials excluded. Our summary of methylene blue’s brain and cellular research lists the rest of the evidence.
Nicotinamide riboside (NR)
In the first human pharmacokinetic trial, single doses of 100, 300 and 1,000 mg of NR raised the blood NAD+ metabolome in a dose-dependent way. The study was sponsored by ChromaDex, which supplies NR (Trammell et al., 2016).
A 2018 crossover trial randomized 30 healthy middle-aged and older adults to 500 mg of NR twice a day (1,000 mg a day) and placebo, six weeks each, and 24 completed it. NR raised NAD+ in blood immune cells by about 60% compared with placebo and was well tolerated. Effects on blood pressure and arterial stiffness were exploratory and need larger trials. The authors also noted that their dose was higher than the label-recommended dose (Martens et al., 2018).
Nicotinamide mononucleotide (NMN)
In a 2022 trial in healthy older men, 250 mg of NMN a day for 6 or 12 weeks raised blood NAD+ and was well tolerated. Gait speed and left grip performance improved only nominally, and body composition did not change. Three authors were employees of the NMN supplier (Igarashi et al., 2022).
A 2023 trial gave 80 healthy middle-aged adults placebo or 300, 600 or 900 mg of NMN a day for 60 days. Blood NAD+ rose in every NMN group, most at 600 and 900 mg, and six-minute walking distance improved compared with placebo. No safety issues were found. The trial was funded by the two companies that made the NMN tested (Yi et al., 2023).
NR vs NMN, head to head
A 2026 randomized, placebo-controlled study in Nature Metabolism compared the two directly in 65 healthy adults. Fourteen days of NR or NMN raised circulating NAD+ by a similar amount, while plain nicotinamide did not. The researchers were Nestlé employees (Christen et al., 2026).
What no trial has shown
Raising blood NAD+ is well established. Turning that into a benefit people can feel is not. A 2025 meta-analysis of randomized trials in adults over 60 concluded that current evidence does not support NMN or NR for preserving muscle mass and function (Prokopidis et al., 2025). For methylene blue, the human evidence is a single dose far larger than a supplement serving. Neither compound has a trial showing that it raises everyday energy in healthy people.
Safety: methylene blue vs NAD+
Methylene blue
The prescribing information for methylene blue injection carries a boxed warning: combined with serotonergic drugs and opioids, it can cause serious or fatal serotonin syndrome. It tells clinicians to avoid SSRIs, SNRIs, MAOIs and opioids, and its interaction section adds bupropion, buspirone, clomipramine, mirtazapine, linezolid and dextromethorphan (methylene blue injection prescribing information). In a review of the reported cases, Gillman found that an intravenous dose of only 0.75 mg/kg reached levels that inhibit MAO-A in the brain (Gillman, 2011). No study has measured how strongly a 5 mg oral dose does this, so apply the same rule to supplements.
The same label rules out methylene blue for people with G6PD deficiency, because of the risk of hemolytic anemia. It warns of potential harm to a fetus and advises stopping breastfeeding for up to eight days after a dose. The dye passes into urine and turns it blue or green, which is expected. Our methylene blue interaction reference, the guide to who should not take methylene blue and the page on methylene blue and G6PD deficiency cover these rules in full.
NR and NMN
The trials above reported NR and NMN as well tolerated. In the 2018 NR trial, 7 of the 30 participants reported side effects, all mild: nausea, flushing, leg cramps and bruising during NR, and headache, rash, flushing, fainting and drowsiness during placebo (Martens et al., 2018). The 2023 NMN trial found no safety issues at up to 900 mg a day for 60 days. The limits are real, though. These trials were short, small and in healthy volunteers, and they were not designed to find drug interactions.
Can you take methylene blue and NAD+ together?
Nothing in their chemistry suggests the two interfere with each other, and on paper they complement each other through NADH. But no human trial has tested the combination, and the clinic infusions that pair them have no published outcome data that we could find. If you want to try both, add one at a time. Take the first on its own for two weeks, note how you feel, then add the second, so you can tell which one is doing what. The methylene blue rules still apply in full: no serotonergic medicines, no G6PD deficiency, not in pregnancy.
Our page on taking NMN and methylene blue together covers the NMN pairing specifically, and our NMN vs methylene blue comparison looks at that choice head to head.
What not to mix with NAD+ or with methylene blue
Methylene blue: do not combine it with SSRIs, SNRIs, MAOIs, bupropion, buspirone, clomipramine, mirtazapine, linezolid, opioids or dextromethorphan. Also avoid serotonin-raising supplements such as 5-HTP, L-tryptophan and St John’s wort, and ask your prescriber before combining it with stimulant medicines. Our guide to methylene blue and serotonin syndrome explains why.
NAD+ precursors: there is little published interaction data. The trials were short and enrolled healthy people, so the absence of reported interactions is not proof that none exist. If you take prescription medicines, ask your pharmacist before adding NR or NMN.
Why do some people say they feel good on methylene blue?
People ask this often, and there is no research on it. No trial has measured mood or well-being after supplement doses of methylene blue. What is known is that methylene blue does two things in the brain: it changes electron flow in mitochondria, and it blocks MAO-A, the enzyme that clears serotonin and norepinephrine. The second action is exactly why it is dangerous alongside serotonergic medicines. If you notice a strong change in how you feel, take that as a reason to keep the dose low, not to raise it.
Which should you choose?
| If this describes you | Consider |
|---|---|
| You take an SSRI, SNRI or other serotonergic medicine | Not methylene blue. Ask your prescriber whether an NAD+ precursor is suitable |
| You have G6PD deficiency, or are pregnant or breastfeeding | Not methylene blue |
| You take no interacting medicine and want a supplement that supports mitochondrial energy, at under a dollar a serving | Methylene blue, starting at 5 mg |
| Your aim is specifically to raise NAD+ levels | NR or NMN, the compounds with trial data for that |
| You want to try both | One at a time, two weeks apart, with the methylene blue rules above |
If you choose an NAD+ precursor, read the label for the form (NR or NMN), the amount per capsule, and whether the brand publishes third-party test results. Compare the dose with the 250 to 1,000 mg a day used in the trials above, and work out the price per 250 mg so you can compare brands fairly.
If you try methylene blue: dose, timing and format
Start low. One 5 mg methylene blue capsule or 10 drops of our 1% methylene blue drops (0.5 mg per drop) gives 5 mg. The methylene blue gummies hold 10 mg each with 25 mg of vitamin C. Our guide to how many mg of methylene blue per day explains how people adjust from there, and the page on taking methylene blue in the morning or at night covers timing.
Expect blue or green urine. Everyone who took methylene blue in the 2016 trial reported blue urine afterwards, and our guide to methylene blue urine color explains how long it lasts. For quality, check what a brand’s testing covers. NooBlue publishes the Contract Testing Laboratories of America (CTLA) report on its methylene blue ingredient, with an HPLC identity result of “Conforms” and individual heavy metal results. That report covers the raw ingredient lot, not each finished batch.
For wider comparisons, see our roundups of the best methylene blue supplements and the best mitochondrial support supplements, our methylene blue vs CoQ10 comparison, or browse all our buying guides and the NooBlue blog.
Methylene blue vs NAD+: frequently asked questions
Is methylene blue better than NAD+ for cellular energy?
Neither has been shown to raise everyday energy in healthy people. Methylene blue acts on electron flow directly and changed brain activity within an hour of a single 280 mg dose in one trial. NR and NMN reliably raise blood NAD+, but trials have not linked that to feeling more energetic. NAD+ precursors are the option for people who cannot take methylene blue because of serotonergic medicines.
Can I take methylene blue and NAD at the same time?
There is no known interaction between them, but no trial has tested the pair. Start one, wait two weeks, then add the other. Do not take methylene blue at all if you use SSRIs, SNRIs or other serotonergic medicines, have G6PD deficiency, or are pregnant or breastfeeding.
Does methylene blue increase NAD+?
It changes the balance rather than the total. Methylene blue takes electrons from NADH, which turns NADH back into NAD+. In human fibroblasts grown in the lab it caused a transient rise in the NAD/NADH ratio. NR and NMN are the compounds that raise the total amount, and that has only been measured in people for them.
Which is better, NMN or NR?
In the only head-to-head trial we found, 14 days of either raised circulating NAD+ by a similar amount in healthy adults. NMN is one step closer to NAD+ in the pathway, but that did not make a measurable difference in that trial. A 2025 meta-analysis found that neither is supported for preserving muscle mass and function in adults over 60.
Is IV NAD+ better than oral precursors?
There is no trial showing that. In a 2019 pilot study, NAD+ infused over six hours did not raise plasma NAD+ for the first two hours, because the body cleared it as fast as it arrived. Oral NR and NMN have more human data behind them.
Why does methylene blue turn urine blue?
Methylene blue is a dye, and it passes into urine. The color is expected and fades as the dose clears. Everyone who took it in the 2016 brain imaging trial reported blue urine.
How much methylene blue should I take?
Supplement servings are 5 to 10 mg. Start with 5 mg a day and judge it over two weeks before changing anything. The 280 mg single dose used in the brain imaging trials is far above supplement amounts and is not a guide for daily use.
The bottom line
Methylene blue and NAD+ precursors approach the same energy pathway from opposite ends. Methylene blue recycles NADH into NAD+ and has a small, single-dose human evidence base. NR and NMN add to the NAD+ pool and have more trials, which show higher blood NAD+ but no clear felt benefit yet. If you take no serotonergic medicine and want to try methylene blue, our pick is the NooBlue 5 mg capsule: a fixed, low starting dose at $0.63 a serving. If you cannot take methylene blue, or you specifically want higher NAD+ levels, NR or NMN is the option to discuss with your doctor.
Sources
- Wen Y, Li W, Poteet EC, et al. Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J Biol Chem. 2011;286(18):16504-16515. PubMed 21454572.
- Atamna H, Nguyen A, Schultz C, et al. Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways. FASEB J. 2008;22(3):703-712. PubMed 17928358.
- Atamna H, Atamna W, Al-Eyd G, Shanower G, Dhahbi JM. Combined activation of the energy and cellular-defense pathways may explain the potent anti-senescence activity of methylene blue. Redox Biol. 2015;6:426-435. PubMed 26386875.
- Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol. 2007;152(6):946-951. PubMed 17721552.
- Gillman PK. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. J Psychopharmacol. 2011;25(3):429-436. PubMed 20142303.
- ProvayBlue (methylene blue) injection, prescribing information. American Regent. DailyMed.
- Rodriguez P, Zhou W, Barrett DW, et al. Multimodal randomized functional MR imaging of the effects of methylene blue in the human brain. Radiology. 2016;281(2):516-526. PubMed 27351678.
- Rodriguez P, Singh AP, Malloy KE, et al. Methylene blue modulates functional connectivity in the human brain. Brain Imaging Behav. 2017;11(3):640-648. PubMed 26961091.
- Clement J, Wong M, Poljak A, Sachdev P, Braidy N. The plasma NAD+ metabolome is dysregulated in “normal” aging. Rejuvenation Res. 2019;22(2):121-130. PubMed 30124109.
- Grant R, Berg J, Mestayer R, et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Front Aging Neurosci. 2019;11:257. PubMed 31572171.
- Trammell SA, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016;7:12948. PubMed 27721479.
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. PubMed 29599478.
- Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging. 2022;8(1):5. PubMed 35927255.
- Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29-43. PubMed 36482258.
- Christen S, Redeuil K, Goulet L, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nat Metab. 2026;8(1):62-73. PubMed 41540253.
- Prokopidis K, Moriarty F, Bahat G, et al. The effect of nicotinamide mononucleotide and riboside on skeletal muscle mass and function: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2025;16(3):e13799. PubMed 40275690.
